Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Rosa Metella Refini"'
Publikováno v:
Oxygen, Vol 2, Iss 3, Pp 371-381 (2022)
This narrative paper reviews the current knowledge of Home Oxygen Therapy (HOT) in stable Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD), two major causes of Long-Term Oxygen Therapy (LTOT) prescription. There is evi
Externí odkaz:
https://doaj.org/article/4b6e71694f9849cfac18440da2f47246
Autor:
David Bennett, Paolo Cameli, Nicola Lanzarone, Loredana Carobene, Nicola Bianchi, Annalisa Fui, Luigi Rizzi, Laura Bergantini, Giuseppe Cillis, Miriana d’Alessandro, Maria Antonietta Mazzei, Rosa Metella Refini, Piersante Sestini, Elena Bargagli, Paola Rottoli
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes,
Externí odkaz:
https://doaj.org/article/838aabdc929b40fab269a81b03d21057
Autor:
Tommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, Maddalena Messina, Beatrice Perea, Simona Luzzi, Laura Bergantini, Miriana D’Alessandro, Rosa Metella Refini, Elena Bargagli, Paolo Cameli
Publikováno v:
Antioxidants, Vol 12, Iss 2, p 400 (2023)
Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation. Its role in the management of severe asthmatic patients undergoing biologic treatment, as we
Externí odkaz:
https://doaj.org/article/3c273887465d4d1d83a684b0bc69da75
Autor:
Paolo Cameli, Valerio Alonzi, Miriana d’Alessandro, Laura Bergantini, Elena Pordon, Marco Guerrieri, Rosa Metella Refini, Piersante Sestini, Elena Bargagli
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 1973 (2022)
Background: Nintedanib is an oral multitarget tyrosine kinase inhibitor approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Recent evidence demonstrated that nintedanib reduced functional disease progression also in subje
Externí odkaz:
https://doaj.org/article/43befbd2cc1542c7a21a6fd4eb74f27a
Autor:
Paolo Cameli, Carla Caffarelli, Rosa Metella Refini, Laura Bergantini, Miriana d'Alessandro, Martina Armati, Maria Dea Tomai Pitinca, Piersante Sestini, Stefano Gonnelli, Elena Bargagli
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Changes in calcium metabolism are quite common in sarcoidosis: hypercalciuria is linked to a persistent clinical phenotype and more active disease. No data is yet available on the specificity of parameters of calcium metabolism as biomark
Externí odkaz:
https://doaj.org/article/3a2e62ac164f47378827a9044795923d
Autor:
Paolo Cameli, Rosa Metella Refini, Laura Bergantini, Miriana d’Alessandro, Valerio Alonzi, Carlo Magnoni, Paola Rottoli, Piersante Sestini, Elena Bargagli
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
BackgroundPirfenidone and nintedanib are the sole pharmacological therapies currently approved for idiopathic pulmonary fibrosis (IPF). Limited comparison data is available in literature, despite they are both prescribed for mild-to-moderate disease.
Externí odkaz:
https://doaj.org/article/42a0ca1d9b58475d9c4c22581ca868e8
Autor:
Lucia Vietri, Paolo Cameli, Marco Perruzza, Behar Cekorja, Laura Bergantini, Miriana d’Alessandro, Rosa Metella Refini, Maria Pieroni, Antonella Fossi, David Bennett, Marco Spalletti, Maria Antonietta Mazzei, Piersante Sestini, Paola Rottoli, Elena Bargagli
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 14 (2020)
Background: Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia and has a median survival after diagnosis of 2–5 years. Pirfenidone is the first approved antifibrotic drug for the treatment of IPF. Here we repor
Externí odkaz:
https://doaj.org/article/d3caa0d35a414d2eab02e76af6f8e9b5
Autor:
David Bennett, Paolo Cameli, Nicola Lanzarone, Loredana Carobene, Nicola Bianchi, Annalisa Fui, Luigi Rizzi, Laura Bergantini, Giuseppe Cillis, Miriana d’Alessandro, Maria Antonietta Mazzei, Rosa Metella Refini, Piersante Sestini, Elena Bargagli, Paola Rottoli
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-1 (2020)
After publication of our article [1] the authors have notified us that one of the names has been incorrectly tagged.
Externí odkaz:
https://doaj.org/article/ff55315132074144b68ae488bab9f00b
Autor:
David Bennett, Elena Bargagli, Rosa Metella Refini, Maria Grazia Pieroni, Antonella Fossi, Riccardo Romeo, Luca Volterrani, Maria Antonietta Mazzei, Paola Rottoli
Publikováno v:
International Journal of Occupational Medicine and Environmental Health, Vol 28, Iss 4, Pp 775-779 (2015)
The natural course of idiopathic pulmonary fibrosis (IPF) is unpredictable at the time of diagnosis. Some patients may experience episodes of acute respiratory worsening that have been termed acute exacerbations. A 58-year-old male was admitted to ou
Externí odkaz:
https://doaj.org/article/76ae79a6a50e447d9a9a6962904b0b82
Autor:
David Bennett, Laura Bergantini, Pierluigi Ferrara, Maria Grazia Cusi, Sabino Scolletta, Francesca Montagnani, Piero Paladini, Piersante Sestini, Rosa Metella Refini, Luca Luzzi, Antonella Fossi, Elena Bargagli
Publikováno v:
Lung. 200:513-522
Background Cytomegalovirus (CMV) is the major and most common opportunistic infection complicating lung transplant (LTX). The aim of this study was to analyse the epidemiological aspects of CMV infection in lung transplant patients subject to a pre-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60fb18c4c409e8c3ed5c3f3df9e264db
https://doi.org/10.1007/s00408-022-00551-0
https://doi.org/10.1007/s00408-022-00551-0